|
England and Wales
|
001-35573
|
98-1467236
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
263 Tresser Boulevard, Suite 1100
|
|
Laporte Road, Stallingborough
|
|
Stamford, Connecticut 06901
|
|
Grimsby, North East Lincolnshire, DN40 2PR, UK
|
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Title of each class
|
Trading Symbol(s)
|
Name of exchange on which registered
|
|
Ordinary shares, par value $0.01 per share
|
TROX
|
NYSE
|
| Item 2.02. |
Results of Operations and Financial Condition.
|
| Item 9.01. |
Financial Statements and Exhibits.
|
|
(d)
|
Exhibits.
|
|
Exhibit No.
|
|
Description
|
|
|
Earnings Release, dated November 5, 2025.
|
|
| 104 |
|
Inline XBRL for the cover page of this Current Report on Form 8-K.
|
|
|
|
TRONOX HOLDINGS PLC
|
|
|
|
|
||
|
Date: November 6, 2025
|
By:
|
/s/ Jeffrey N. Neuman
|
|
|
|
|
Name:
|
Jeffrey N. Neuman
|
|
|
|
Title:
|
Senior Vice President, General Counsel and Secretary
|

| • |
Revenue of $699 million, a 4% decrease compared to the prior quarter and a 13% decrease compared to the prior year
|
| • |
Loss from operations of $43 million; Net loss attributable to Tronox of $99 million including $27 million of restructuring and other charges, net of taxes, primarily costs associated with the closure of the Company's Botlek pigment plant as announced in March; adjusted net loss
attributable to Tronox was $72 million (non-GAAP)
|
| • |
GAAP diluted loss per share was $0.63; Adjusted diluted loss per share was $0.46 (non-GAAP)
|
| • |
Adjusted EBITDA of $74 million; Adjusted EBITDA margin of 10.6% (non-GAAP)
|
| • |
Capital expenditures of $80 million in the quarter
|
| • |
Expect Q4 2025 revenue and Adjusted EBITDA to be relatively flat to Q3 2025 and free cash flow to be a source in the quarter
|
| • |
Assumes TiO2 volume growth of 3-5% and zircon volume growth of 15-20% compared to Q3 2025, offset by unanticipated headwinds on TiO2 and zircon pricing of ~2% and ~6%,
respectively
|
|
($M unless otherwise noted)
|
Q3 2025
|
Q3 2024
|
Y-o-Y%∆
|
|
Q2 2025
|
Q-o-Q%∆
|
|
|||||||||||||
|
Revenue
|
$
|
699
|
$
|
804
|
(13
|
)%
|
$
|
731
|
(4
|
)%
|
||||||||||
|
TiO2
|
$
|
550
|
$
|
616
|
(11
|
)%
|
$
|
587
|
(6
|
)%
|
||||||||||
|
Zircon
|
$
|
59
|
$
|
74
|
(20
|
)%
|
$
|
68
|
(13
|
)%
|
||||||||||
|
Other products
|
$
|
90
|
$
|
114
|
(21
|
)%
|
$
|
76
|
18
|
%
|
||||||||||
|
(Loss) Income from operations
|
$
|
(43
|
)
|
$
|
54
|
n/m
|
|
$
|
(35
|
)
|
n/m
|
|
||||||||
|
Net Loss attributable to Tronox
|
$
|
(99
|
)
|
$
|
(25
|
)
|
n/m
|
|
$
|
(84
|
)
|
n/m
|
|
|||||||
|
GAAP diluted loss per share
|
$
|
(0.63
|
)
|
$
|
(0.16
|
)
|
n/m
|
|
$
|
(0.53
|
)
|
n/m
|
|
|||||||
|
Adjusted diluted loss per share
|
$
|
(0.46
|
)
|
$
|
(0.13
|
)
|
n/m
|
|
$
|
(0.28
|
)
|
n/m
|
|
|||||||
|
Adjusted EBITDA
|
$
|
74
|
$
|
143
|
(48
|
)%
|
$
|
93
|
(20
|
)%
|
||||||||||
|
Adjusted EBITDA Margin %
|
|
10.6
|
%
|
|
17.8
|
%
|
|
(720) bps |
|
12.7
|
%
|
|
(210) bps
|
|
||||||
|
Free cash flow
|
$
|
(137
|
)
|
$
|
(14
|
)
|
n/m
|
|
$
|
(55
|
)
|
n/m
|
|
|
|
||||||
|
Y-o-Y % ∆
|
Q-o-Q % ∆
|
|||||
|
Volume
|
Price / Mix
|
FX
|
Volume
|
Price / Mix
|
FX
|
|
|
TiO2
|
(8)%
|
(5)%
|
2%
|
(4)%
|
(3)%
|
1%
|
|
Zircon
|
(4)%
|
(16)%
|
—
|
(7)%
|
(6)%
|
—
|
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net sales
|
$
|
699
|
$
|
804
|
$
|
2,168
|
$
|
2,398
|
||||||||
|
Cost of goods sold
|
647
|
676
|
1,938
|
2,000
|
||||||||||||
|
Gross profit
|
52
|
128
|
230
|
398
|
||||||||||||
|
Restructuring and other charges
|
25
|
—
|
153
|
—
|
||||||||||||
|
Selling, general and administrative expenses
|
70
|
74
|
216
|
227
|
||||||||||||
|
(Loss) Income from operations
|
(43
|
)
|
54
|
(139
|
)
|
171
|
||||||||||
|
Interest expense
|
(48
|
)
|
(42
|
)
|
(135
|
)
|
(126
|
)
|
||||||||
|
Interest income
|
1
|
3
|
4
|
9
|
||||||||||||
|
Loss on extinguishment of debt
|
—
|
(3
|
)
|
—
|
(3
|
)
|
||||||||||
|
Other (expense) income, net
|
(2
|
)
|
(11
|
)
|
(9
|
)
|
7
|
|||||||||
|
(Loss) Income before income taxes
|
(92
|
)
|
1
|
(279
|
)
|
58
|
||||||||||
|
Income tax provision
|
(8
|
)
|
(26
|
)
|
(17
|
)
|
(82
|
)
|
||||||||
|
Net loss
|
(100
|
)
|
(25
|
)
|
(296
|
)
|
(24
|
)
|
||||||||
|
Net loss attributable to noncontrolling interest
|
(1
|
)
|
—
|
(2
|
)
|
(6
|
)
|
|||||||||
|
Net loss attributable to Tronox Holdings plc
|
$
|
(99
|
)
|
$
|
(25
|
)
|
$
|
(294
|
)
|
$
|
(18
|
)
|
||||
|
Loss per share:
|
||||||||||||||||
|
Basic
|
$
|
(0.63
|
)
|
$
|
(0.16
|
)
|
$
|
(1.85
|
)
|
$
|
(0.11
|
)
|
||||
|
Diluted
|
$
|
(0.63
|
)
|
$
|
(0.16
|
)
|
$
|
(1.85
|
)
|
$
|
(0.11
|
)
|
||||
|
Weighted average shares outstanding, basic (in thousands)
|
158,600
|
158,095
|
158,439
|
157,811
|
||||||||||||
|
Weighted average shares outstanding, diluted (in thousands)
|
158,600
|
158,095
|
158,439
|
157,811
|
||||||||||||
|
Other Operating Data:
|
||||||||||||||||
|
Capital expenditures
|
80
|
101
|
273
|
253
|
||||||||||||
|
Depreciation, depletion and amortization expense
|
75
|
70
|
220
|
214
|
||||||||||||
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net loss attributable to Tronox Holdings plc (U.S. GAAP)
|
$
|
(99
|
)
|
$
|
(25
|
)
|
$
|
(294
|
)
|
$
|
(18
|
)
|
||||
|
Restructuring and other charges (a)
|
25
|
—
|
150
|
—
|
||||||||||||
|
Loss on extinguishment of debt (b)
|
—
|
3
|
—
|
3
|
||||||||||||
|
Tax valuation allowance (c)
|
—
|
—
|
—
|
16
|
||||||||||||
|
Sale of royalty interest (d)
|
—
|
—
|
—
|
(21
|
)
|
|||||||||||
|
Other (e)
|
2
|
1
|
3
|
4
|
||||||||||||
|
Adjusted net loss attributable to Tronox Holdings plc (non-U.S. GAAP) (1)
|
$
|
(72
|
)
|
$
|
(21
|
)
|
$
|
(141
|
)
|
$
|
(16
|
)
|
||||
|
Diluted net loss per share (U.S. GAAP)
|
$
|
(0.63
|
)
|
$
|
(0.16
|
)
|
$
|
(1.85
|
)
|
$
|
(0.11
|
)
|
||||
|
Restructuring and other charges, per share
|
0.16
|
—
|
0.94
|
—
|
||||||||||||
|
Loss on extinguishment of debt, per share
|
—
|
0.02
|
—
|
0.02
|
||||||||||||
|
Tax valuation allowance, per share
|
—
|
—
|
—
|
0.10
|
||||||||||||
|
Sale of royalty interest, per share
|
—
|
—
|
—
|
(0.14
|
)
|
|||||||||||
|
Other, per share
|
0.01
|
0.01
|
0.02
|
0.03
|
||||||||||||
|
Diluted adjusted net loss per share attributable to Tronox Holdings plc (non-U.S. GAAP) (2)
|
$ |
(0.46) |
$
|
(0.13
|
)
|
$
|
(0.89
|
)
|
$
|
(0.10
|
)
|
|||||
|
Weighted average shares outstanding, diluted (in thousands)
|
158,600
|
158,095
|
158,439
|
157,811
|
||||||||||||
|
September 30, 2025
|
December 31, 2024
|
|||||||
|
ASSETS
|
||||||||
|
Current Assets
|
||||||||
|
Cash and cash equivalents
|
$
|
185
|
$
|
151
|
||||
|
Restricted cash
|
1
|
1
|
||||||
|
Accounts receivable (net of allowance for credit losses of $1 and $1 as of September 30, 2025
and December 31, 2024, respectively)
|
301
|
266
|
||||||
|
Inventories, net
|
1,688
|
1,551
|
||||||
|
Prepaid and other assets
|
131
|
184
|
||||||
|
Income taxes receivable
|
2
|
2
|
||||||
|
Total current assets
|
2,308
|
2,155
|
||||||
|
Noncurrent Assets
|
||||||||
|
Property, plant and equipment, net
|
2,024
|
1,927
|
||||||
|
Mineral leaseholds, net
|
610
|
616
|
||||||
|
Intangible assets, net
|
221
|
244
|
||||||
|
Lease right of use assets, net
|
178
|
140
|
||||||
|
Deferred tax assets
|
832
|
830
|
||||||
|
Other long-term assets
|
130
|
126
|
||||||
|
Total assets
|
$
|
6,303
|
$
|
6,038
|
||||
|
LIABILITIES AND EQUITY
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable
|
$
|
433
|
$
|
499
|
||||
|
Accrued liabilities
|
238
|
247
|
||||||
|
Short-term lease liabilities
|
27
|
24
|
||||||
|
Obligations under inventory financing arrangement
|
50
|
—
|
||||||
|
Short-term debt
|
58
|
65
|
||||||
|
Long-term debt due within one year
|
39
|
35
|
||||||
|
Income taxes payable
|
2
|
4
|
||||||
|
Total current liabilities
|
847
|
874
|
||||||
|
Noncurrent Liabilities
|
||||||||
|
Long-term debt, net
|
3,136
|
2,759
|
||||||
|
Pension and postretirement healthcare benefits
|
90
|
85
|
||||||
|
Asset retirement obligations
|
213
|
172
|
||||||
|
Environmental liabilities
|
31
|
40
|
||||||
|
Long-term lease liabilities
|
147
|
107
|
||||||
|
Deferred tax liabilities
|
201
|
174
|
||||||
|
Other long-term liabilities
|
45
|
36
|
||||||
|
Total liabilities
|
4,710
|
4,247
|
||||||
|
Commitments and Contingencies
|
||||||||
|
Shareholders’ Equity
|
||||||||
|
Tronox Holdings plc ordinary shares, par value $0.01 — 158,552,328 shares issued and outstanding
at September 30, 2025 and 157,938,056 shares issued and outstanding at December 31, 2024
|
2
|
2
|
||||||
|
Capital in excess of par value
|
2,097
|
2,084
|
||||||
|
Retained earnings
|
213
|
555
|
||||||
|
Accumulated other comprehensive loss
|
(751
|
)
|
(880
|
)
|
||||
|
Total Tronox Holdings plc shareholders’ equity
|
1,561
|
1,761
|
||||||
|
Noncontrolling interest
|
32
|
30
|
||||||
|
Total equity
|
1,593
|
1,791
|
||||||
|
Total liabilities and equity
|
$
|
6,303
|
$
|
6,038
|
||||
|
Nine Months Ended September 30,
|
||||||||
|
2025
|
2024
|
|||||||
|
Cash Flows from Operating Activities:
|
||||||||
|
Net loss
|
$
|
(296
|
)
|
$
|
(24
|
)
|
||
|
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
|
||||||||
|
Depreciation, depletion and amortization
|
220
|
214
|
||||||
|
Deferred income taxes
|
14
|
64
|
||||||
|
Share-based compensation expense
|
14
|
17
|
||||||
|
Amortization of deferred debt issuance costs and discount on debt
|
7
|
7
|
||||||
|
Loss on extinguishment of debt
|
-
|
3
|
||||||
|
Restructuring and other charges
|
153
|
-
|
||||||
|
Other non-cash items affecting net loss
|
43
|
24
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
Increase in accounts receivable, net of allowance for credit losses
|
(24
|
)
|
(82
|
)
|
||||
|
Increase in inventories, net
|
(73
|
)
|
(11
|
)
|
||||
|
Decrease in prepaid and other assets
|
39
|
32
|
||||||
|
Restructuring payments
|
(57
|
)
|
-
|
|||||
|
Decrease in accounts payable and accrued liabilities
|
(70
|
)
|
(2
|
)
|
||||
|
Net changes in income tax payables and receivables
|
(2
|
)
|
8
|
|||||
|
Changes in other non-current assets and liabilities
|
(29
|
)
|
(32
|
)
|
||||
|
Cash (used in) provided by operating activities
|
(61
|
)
|
218
|
|||||
|
Cash Flows from Investing Activities:
|
||||||||
|
Capital expenditures
|
(273
|
)
|
(253
|
)
|
||||
|
Loans
|
15
|
-
|
||||||
|
Proceeds from sale of assets
|
3
|
27
|
||||||
|
Cash used in investing activities
|
(255
|
)
|
(226
|
)
|
||||
|
Cash Flows from Financing Activities:
|
||||||||
|
Repayments of short-term debt
|
(136
|
)
|
(12
|
)
|
||||
|
Repayments of long-term debt
|
(21
|
)
|
(221
|
)
|
||||
|
Proceeds from long-term debt
|
400
|
212
|
||||||
|
Proceeds from short-term debt
|
100
|
-
|
||||||
|
Proceeds from inventory financing arrangement
|
50
|
-
|
||||||
|
Debt issuance costs
|
(7
|
)
|
(14
|
)
|
||||
|
Dividends paid
|
(40
|
)
|
(61
|
)
|
||||
|
Restricted stock and performance-based shares settled in cash for withholding taxes
|
(1
|
)
|
(1
|
)
|
||||
|
Cash provided by (used in) financing activities
|
345
|
(97
|
)
|
|||||
|
Effects of exchange rate changes on cash and cash equivalents and restricted cash
|
5
|
-
|
||||||
|
Net increase (decrease) in cash and cash equivalents and restricted cash
|
34
|
(105
|
)
|
|||||
|
Cash and cash equivalents and restricted cash at beginning of period
|
152
|
273
|
||||||
|
Cash and cash equivalents and restricted cash at end of period
|
$
|
186
|
$
|
168
|
||||
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net loss (U.S. GAAP)
|
$
|
(100
|
)
|
$
|
(25
|
)
|
(296
|
)
|
(24
|
)
|
||||||
|
Interest expense
|
48
|
42
|
135
|
126
|
||||||||||||
|
Interest income
|
(1
|
)
|
(3
|
)
|
(4
|
)
|
(9
|
)
|
||||||||
|
Income tax provision
|
8
|
26
|
17
|
82
|
||||||||||||
|
Depreciation, depletion and amortization expense
|
75
|
70
|
220
|
214
|
||||||||||||
|
EBITDA (non-U.S. GAAP)
|
30
|
110
|
72
|
389
|
||||||||||||
|
Share-based compensation (a)
|
5
|
7
|
14
|
17
|
||||||||||||
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (b)
|
6
|
8
|
20
|
22
|
||||||||||||
|
Accounts receivable securitization program (c)
|
3
|
4
|
10
|
11
|
||||||||||||
|
Foreign currency remeasurement (d)
|
—
|
8
|
(1
|
)
|
10
|
|||||||||||
|
Sale of royalty interest (e)
|
—
|
—
|
—
|
(28
|
)
|
|||||||||||
|
Restructuring and other charges (f)
|
25
|
—
|
153
|
—
|
||||||||||||
|
Loss on extinguishment of debt (g)
|
—
|
3
|
—
|
3
|
||||||||||||
|
Other items (h)
|
5
|
3
|
11
|
11
|
||||||||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
74
|
$
|
143
|
$
|
279
|
$
|
435
|
||||||||
|
Three Months Ended September 30,
|
||||||||
|
2025
|
2024
|
|||||||
|
Net sales
|
$
|
699
|
$
|
804
|
||||
|
Net loss (U.S. GAAP)
|
$
|
(100
|
)
|
$
|
(25
|
)
|
||
|
Net loss (U.S. GAAP) as a % of Net sales
|
(14.3
|
)%
|
(3.1
|
)%
|
||||
|
Adjusted EBITDA (non-U.S. GAAP) (see above) as a % of Net sales
|
10.6
|
%
|
17.8
|
%
|
||||
|
September 30, 2025
|
December 31, 2024
|
|||||||
|
Long-term debt, net
|
$
|
3,136
|
$
|
2,759
|
||||
|
Short-term debt
|
58
|
65
|
||||||
|
Long-term debt due within one year
|
39
|
35
|
||||||
|
(Less) Cash and cash equivalents
|
(185
|
)
|
(151
|
)
|
||||
|
Net debt
|
$
|
3,048
|
$
|
2,708
|
||||
|
Trailing-twelve month Adjusted EBITDA (non-U.S. GAAP)
|
$
|
408
|
$
|
564
|
||||
|
Net debt to trailing-twelve month Adjusted EBITDA (non-U.S. GAAP) (see above)
|
7.5
|
x
|
4.8
|
x
|
||||
|
Nine Months Ended
September 30, 2025
|
Six Months Ended
June 30, 2025
|
Three Months Ended
September 30, 2025
|
||||||||||
|
Cash used in operating activities
|
$
|
(61
|
)
|
$
|
(4
|
)
|
$
|
(57
|
)
|
|||
|
Capital expenditures
|
(273
|
)
|
(193
|
)
|
(80
|
)
|
||||||
|
Free cash flow (non-U.S. GAAP)
|
$
|
(334
|
)
|
$
|
(197
|
)
|
$
|
(137
|
)
|
|||
|
Three Months Ended
|
Trailing Twelve Month
Adjusted EBITDA
|
|||||||||||||||||||
|
December 31, 2024
|
March 31, 2025
|
June 30, 2025
|
September 30, 2025
|
|||||||||||||||||
|
Net loss (U.S. GAAP)
|
$
|
(30
|
)
|
$
|
(111
|
)
|
$
|
(85
|
)
|
$
|
(100
|
)
|
$
|
(326
|
)
|
|||||
|
Interest expense
|
41
|
42
|
45
|
48
|
176
|
|||||||||||||||
|
Interest income
|
(1
|
)
|
(2
|
)
|
(1
|
)
|
(1
|
)
|
(5
|
)
|
||||||||||
|
Income tax provision
|
45
|
5
|
4
|
8
|
62
|
|||||||||||||||
|
Depreciation, depletion and amortization expense
|
71
|
71
|
74
|
75
|
291
|
|||||||||||||||
|
EBITDA (non-U.S. GAAP)
|
126
|
5
|
37
|
30
|
198
|
|||||||||||||||
|
Share-based compensation (a)
|
4
|
5
|
4
|
5
|
18
|
|||||||||||||||
|
Foreign currency remeasurement (b)
|
(11
|
)
|
1
|
(2
|
)
|
—
|
(12
|
)
|
||||||||||||
|
Accretion expense and other adjustments to asset retirement obligations and
environmental liabilities (c)
|
1
|
7
|
7
|
6
|
21
|
|||||||||||||||
|
Accounts receivable securitization program (d)
|
4
|
4
|
3
|
3
|
14
|
|||||||||||||||
|
Restructuring and other charges (e)
|
—
|
86
|
42
|
25
|
153
|
|||||||||||||||
|
Other items (f)
|
5
|
4
|
2
|
5
|
16
|
|||||||||||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
129
|
$
|
112
|
$
|
93
|
$
|
74
|
$
|
408
|
||||||||||